As mentioned on our Health Industry Washington Watch blog, the FDA will host a public workshop on April 1, 2015 to provide updates on the use of clinical outcome assessments (COAs), as well as to address plans for future development and use of COAs in drug development programs. The workshop, entitled "Clinical Outcomes Assessment Development and Implementation: Opportunities and Challenges," will also cover the inclusion of patient-centered outcome measures, COA usage standards and collaborative processes for the development and dissemination of COAs. Participants may attend in person or via webcast. If you are interested in attending, please register no later than March 27, 2015.
This article is presented for informational purposes only and is not intended to constitute legal advice.